Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel

Fig. 1

Kaplan–Meier curves for PFS (a) and OS (b) in infused patients, matched-adjusted comparison (primary analysis). CI confidence interval, ESS effective sample size, liso-cel lisocabtagene maraleucel, NR not reached, OS overall survival, PFS progression-free survival

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us